| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Pharmacy Practice Act is amended by changing | |||||||||||||||||||
5 | Section 26 as follows: | |||||||||||||||||||
6 | (225 ILCS 85/26) | |||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2018) | |||||||||||||||||||
8 | Sec. 26. Anti-epileptic , atypical anti-psychotic, and | |||||||||||||||||||
9 | targeted immune modulator (TIM) drug product change selection | |||||||||||||||||||
10 | prohibited. | |||||||||||||||||||
11 | (a) The General Assembly finds that this Section is | |||||||||||||||||||
12 | necessary for the immediate preservation of the public peace, | |||||||||||||||||||
13 | health, and safety. | |||||||||||||||||||
14 | (b) In this Section: | |||||||||||||||||||
15 | "Anti-epileptic drug" means (i) any drug prescribed for the | |||||||||||||||||||
16 | treatment of epilepsy or (ii) a drug used to treat or prevent | |||||||||||||||||||
17 | seizures. | |||||||||||||||||||
18 | "Epilepsy" means a neurological condition characterized by | |||||||||||||||||||
19 | recurrent seizures. | |||||||||||||||||||
20 | "Seizure" means a brief disturbance in the electrical | |||||||||||||||||||
21 | activity of the brain. | |||||||||||||||||||
22 | (c) When the prescribing physician has indicated on the | |||||||||||||||||||
23 | original prescription "may not substitute", a pharmacist may |
| |||||||
| |||||||
1 | not interchange an anti-epileptic drug or formulation of an | ||||||
2 | anti-epileptic drug for the treatment of epilepsy , an atypical | ||||||
3 | anti-psychotic drug, or targeted immune modulator (TIM) | ||||||
4 | without notification and the documented consent of the | ||||||
5 | prescribing practitioner physician and the patient or the | ||||||
6 | patient's parent, legal guardian, or spouse.
This Section does | ||||||
7 | not apply to medication orders issued for anti-epileptic drugs , | ||||||
8 | atypical anti-psychotic drugs, or targeted immune modulators | ||||||
9 | for any in-patient care in a licensed hospital.
| ||||||
10 | (d) If a pharmacist substitutes any generic prescription in | ||||||
11 | place of any other a brand-name anti-epileptic drug, atypical | ||||||
12 | anti-psychotic drug, or targeted immune modulator, then the | ||||||
13 | pharmacist shall provide written notice to the patient no later | ||||||
14 | than the time the prescription is dispensed. | ||||||
15 | (e) Nothing in this Section shall be construed to prohibit | ||||||
16 | generic drug substitution as provided for in Section 25 of this | ||||||
17 | Act. | ||||||
18 | (Source: P.A. 97-456, eff. 1-1-12.)
| ||||||
19 | Section 99. Effective date. This Act takes effect upon | ||||||
20 | becoming law.
|